MMIT (Managed Markets Insight & Technology)’s Post

Pharma companies are approaching market access planning early, using real-world data and AI. https://ow.ly/wSwR50SEI0T In Life Science Leader, MMIT and The Dedham Group experts explain why increased financial pressures have resulted in greater investment in market access. #MarketAccess #Pharma #PharmaCompanies

Pharma companies are approaching market access planning early, using real-world data and AI. https://ow.ly/PrMA50SzNIM In Life Science Leader, MMIT and The Dedham Group experts explain why increased financial pressures have resulted in greater investment in market access. #MarketAccess #Pharma #PharmaCompanies

🎯 How Will Machine Learning Transform Market Access?   In an industry where precision and innovation are crucial, the role of machine learning is becoming a game-changer. Imagine the possibilities when advanced algorithms can optimize market access and pricing strategies.    But how exactly will this impact the future of Life Sciences?   At the upcoming session on "Machine Learning in Market Access: A Game-Changer," Sandro Cesaro from AstraZeneca will dive into these questions and more.   Sandro brings his wealth of experience from AstraZeneca, where innovation is at the forefront of their approach. His insights could shape the way we think about market access moving forward.   Join us at EPP Life Sciences Pricing Forum 2024 to explore how technology is not just a tool but a strategic advantage in the Life Sciences sector.   Download our brochure today! https://lnkd.in/d2KYzBZX #EPP #EPPLSPF #LSF24 #LifeSciences #Pharma #Biopharma #Medtech #PricingStrategies #Innovation #Healthcare #LifeSciences2024

Navigator has arrived. Introducing an innovative fusion of pharma consultancy expertise and data-driven insights. Steer your strategic decisions with more accuracy and certainty. Where will your Navigator journey take you? Interested in finding out more? Contact us today: https://lnkd.in/e9SwSYjY #ai #data #insights #healthcare #pharma #InizioAdvisory #InizioNavigator

InsiMine's GenAI solutions deliver unparalleled insights into real-world evidence, revolutionizing drug discovery, optimizing clinical trials, and boosting operational efficiency. By leveraging our advanced GenAI technology, you can accelerate research timelines, enhance decision-making processes, and achieve unprecedented operational excellence.   Read our comprehensive blog on "𝗛𝗮𝗿𝗻𝗲𝘀𝘀𝗶𝗻𝗴 𝘁𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗚𝗲𝗻𝗔𝗜 𝗶𝗻 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲" to delve deeper into how InsiMine caters to enterprises in substantially driving their business operations through informed decision-making: https://insimine.com/blogs #genAI #realworldevidence #drugdiscovery #clinicaltrials #operationalexcellence #AIinhealthcare #pharmainnovation #biotechrevolution #datadrivendecisions #healthcaretechnology #AIresearch #precisionmedicine

Introducing Navigator.  Validate with data.  Prioritize with confidence.  Decide with insight. 👇 Contact Inizio Advisory to find out more: https://lnkd.in/ejEPDgFD #Inizio #InizioAdvisory #InizioNavigator #AI #Data #Healthcare #Pharma

🏥 **Revolutionizing Drug Development with Comprehensive Data Solutions** 💊 *In the fast-paced world of clinical trials and drug development, having access to diverse and high-quality data is a game-changer. 🌟 Imagine a federated network encompassing over **165M+ individuals** from various data sources, including commercial providers, biobanks, and academic centers. 💡 For those navigating the complexities of clinical and multi-omic data, here's how we’re tackling the major challenges of custodianship, standardization, volume, and cost: 🔹 **Substantial discounts by volume** – Maximize your budget while accessing more data. 🔹 **Flexible licensing options** – Choose from monthly or quarterly licenses to suit your project timeline. 🔹 **Adaptive cohort management** – Swap cohorts mid-license to keep your research agile and responsive. 🔹 **Global reach with 60M ex-US individuals** – Gain insights from diverse populations worldwide. 🎯 Our federated querying and analysis capabilities ensure you can extract the most relevant insights seamlessly. Let’s discuss how these solutions can power your next breakthrough in drug development. Cheers to innovation and progress! #ClinicalTrials #DrugDevelopment #BigData #Omics #Biopharma

Proud being part of the team which brought deep drug discovery knowledge amalgamated with power of Machine learning, generativeAI and new age visualizations to execute healthcare consulting projects with greater efficiency and precision. Navigator platform also has state of art in-house developed algorithms to predict likelihood of approval and time to market for early stage pipeline drugs along with many more algorithms to manage uncertainty and make smart decisions. #Inizio #Navigator #healthcareconsulting #generativeai #machinelearning #drugdiscovery #fdaapproval #analyticsinsights

It can be difficult to gauge a brand's success at pre and post launch stages without access to benchmarks. Learn how AI enabled ATU benchmarking provides #ConnectedIntelligence to improve decision making in this on-demand webinar. Watch now: https://bit.ly/3XI5ZgW #MarketResearch #LifeSciences #Pharma

Thrilled about NEXT Pharma Summit CX & AI 24' in Vienna! 🌟 With an impressive lineup of sponsors, this event promises to be a game-changer. Who's ready to dive into the future of pharma and AI? I know that Dario Safaric & Marcus Bergler will be there 😉🚀 Who else? #nextpharmasummit #AI #pharmaCX #Vienna2024"